531752 Stock Overview
Engages in the trading of shares and securities. More details
Snowflake Score | |
---|---|
Valuation | 1/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 4/6 |
Dividends | 0/6 |
Biogen Pharmachem Industries Limited Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | ₹1.23 |
52 Week High | ₹1.85 |
52 Week Low | ₹0.79 |
Beta | -0.38 |
11 Month Change | 3.36% |
3 Month Change | -6.82% |
1 Year Change | 55.70% |
33 Year Change | 105.00% |
5 Year Change | 434.78% |
Change since IPO | 127.78% |
Recent News & Updates
Recent updates
Shareholder Returns
531752 | IN Capital Markets | IN Market | |
---|---|---|---|
7D | 0.8% | 0.9% | 0.5% |
1Y | 55.7% | 66.2% | 27.5% |
Return vs Industry: 531752 underperformed the Indian Capital Markets industry which returned 66.2% over the past year.
Return vs Market: 531752 exceeded the Indian Market which returned 27.5% over the past year.
Price Volatility
531752 volatility | |
---|---|
531752 Average Weekly Movement | 4.5% |
Capital Markets Industry Average Movement | 6.9% |
Market Average Movement | 6.1% |
10% most volatile stocks in IN Market | 9.1% |
10% least volatile stocks in IN Market | 4.0% |
Stable Share Price: 531752 has not had significant price volatility in the past 3 months compared to the Indian market.
Volatility Over Time: 531752's weekly volatility (5%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1995 | n/a | Niraj Vaghela | www.biogenpharma.life |
Biogen Pharmachem Industries Limited engages in the trading of shares and securities. The company was formerly known as Sun Techno Overseas Limited and changed its name to Biogen Pharmachem Industries Limited in March 2021. Biogen Pharmachem Industries Limited was incorporated in 1995 and is based in Rajkot, India.
Biogen Pharmachem Industries Limited Fundamentals Summary
531752 fundamental statistics | |
---|---|
Market cap | ₹802.70m |
Earnings (TTM) | -₹3.52m |
Revenue (TTM) | n/a |
-54.9x
P/S Ratio-228.1x
P/E RatioIs 531752 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
531752 income statement (TTM) | |
---|---|
Revenue | -₹14.62m |
Cost of Revenue | ₹0 |
Gross Profit | -₹14.62m |
Other Expenses | -₹11.10m |
Earnings | -₹3.52m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | -0.0054 |
Gross Margin | 100.00% |
Net Profit Margin | 24.07% |
Debt/Equity Ratio | 0% |
How did 531752 perform over the long term?
See historical performance and comparison